RO6889678
CAS No. 1578153-27-1
RO6889678 ( RO 6889678 )
Catalog No. M12255 CAS No. 1578153-27-1
RO6889678 is a highly potent inhibitor of HBV capsid formation with attributes that are favorable for targeting the liver, whilst maintaining moderate peripheral exposure.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 88 | Get Quote |
|
5MG | 124 | Get Quote |
|
10MG | 178 | Get Quote |
|
25MG | 255 | Get Quote |
|
50MG | 407 | Get Quote |
|
100MG | 599 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameRO6889678
-
NoteResearch use only, not for human use.
-
Brief DescriptionRO6889678 is a highly potent inhibitor of HBV capsid formation with attributes that are favorable for targeting the liver, whilst maintaining moderate peripheral exposure.
-
DescriptionRO6889678 is a highly potent inhibitor of HBV capsid formation with attributes that are favorable for targeting the liver, whilst maintaining moderate peripheral exposure.HBV InfectionPhase 1 Discontinued
-
SynonymsRO 6889678
-
PathwayMicrobiology/Virology
-
TargetHBV
-
RecptorHBV
-
Research AreaInfection
-
IndicationHBV Infection
Chemical Information
-
CAS Number1578153-27-1
-
Formula Weight494.92
-
Molecular FormulaC21H20ClFN4O5S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C([C@H]1N(CC2=C(C(OC)=O)[C@H](C3=CC=C(F)C=C3Cl)N=C(C4=NC=CS4)N2)CCOC1)O
-
Chemical Name(S)-4-(((R)-6-(2-chloro-4-fluorophenyl)-5-(methoxycarbonyl)-2-(thiazol-2-yl)-3,6-dihydropyrimidin-4-yl)methyl)morpholine-3-carboxylic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kratochwil NA, et al. J Pharmacol Exp Ther. 2018 Feb 16. pii: jpet.117.245712.
molnova catalog
related products
-
JNJ-632
JNJ-632 (JNJ632) is a novel potent HVV capsid assembly modulator and HBV replication inhibitor.
-
Inarigivir ammonium
Inarigivir ammonium is a dinucleotide antiviral compound that significantly reduces HBV DNA in transgenic mice expressing hepatitis B virus. Inarigivir is an agonist of retinoic acid-inducible gene-I (RIG-I) that activates intracellular innate immunity.
-
RG7834
RG7834 is a highly selective and orally bioavailable inhibitor of HBV(HBsAg and HBeAg and HBV DNA with IC50s of 2.8, 2.6, and 3.2 nM, respectively, in dHepaRG Cells).